Industry Reports Tuesday, Mar 27, 2018

Fujirebio Europe NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Highlights

Fujirebio Europe NV (Fujirebio Europe), a subsidiary of Fujirebio Inc, is a global healthcare company. It designs, develops and produces in vitro diagnostic (IVD) testing solutions and markets them worldwide. Its diagnostic products consist of Innotest products for ELISA; INNO-LIA products for autoimmune diseases; INNO-LiPA products for line probe assay; INNO-BIA products for bead-based multiparameter immunoassay, and Lumipulse products for chemiluminescent enzyme immunoassay (CLEIA) system. The company products find application in the treatment of infectious diseases, cancer, genetic testing, thyroid, fertility, tissue typing, neurodegeneration and bones. The company markets its products through its subsidiaries and distributors worldwide. Fujirebio Europe is headquartered in Gent, Belgium.

Harvard Medical School - SQIL Program Harvard Medical School - SEAL Program Medical Taiwan International Medical, Health & Care Expo Fotona SP Dynamis Greiner Bio-One -Preanalytics